MY ACCOUNT | NEWSLETTER |

Intestinal and lung parasites in owned dogs and cats from central Italy


Prevalence and risk factors of intestinal and lung parasites were investigated in 239 owned dogs and 81 owned cats from central Italy. In 36 dogs and 20 cats found infected by nematodes, pre and post-treatment faecal egg count (FEC) was also evaluated. About 31% of dogs and about 35% of cats resulted positive for at least one intestinal or lung parasitic species. Helminthic, intestinal and zoonotic infections resulted prevalent in examined animals. Examined dogs resulted infected by Toxocara canis (13.0%), Toxascaris leonina (1.7%), Trichuris vulpis (3.3%), Ancylostoma caninum (2.0%), Uncinaria stenocephala (1.25%), Strongyloides stercoralis (0.8%), Angiostrongylus vasorum (0.4%), Dipylidium caninum (1.25%), Taeniidae eggs (0.4%), Giardia duodenalis (3.8%), and Cystoisospora (Isospora) spp. (7.5%). Examined cats were infected by Toxocara cati (22.2%), Capillaria aerophila (1.2%), Ancylostoma tubaeformae (1.2%), U. stenocephala (3.7%), Aelurostrongylus abstrusus (1.2%), Mesocestoides sp. (1.2%), D. caninum (1.2%), G. duodenalis (1.2%) and Cystoisospora spp. (4.5%). The presence of clinical signs and the young age (less than 6 months) were identified as risk factors by univariate and multivariate statistical analysis. In 63.9% treated dogs and in 80.0% treated cats, percentages of post-treatment FEC reduction higher than 90% were found. Results obtained in this study are discussed.

Introduction

Intestinal and lung parasites are frequently recorded in dogs and cats and can be responsible for severe clinical forms. For these reason they are considered very important pathogens in the clinical practice of these companion animals (De Santis et al., 2006, Sager et al., 2006, Claerebout et al., 2009, Epe, 2009, Traversa et al., 2010). Moreover, intestinal and lung parasites of dogs and cats include zoonotic species raising public health concerns, such as Toxocara spp. and Ancylostoma caninum responsible respectively for human visceral and cutaneous larva migrans or Capillaria aerophila occasionally reported as a cause of human pulmonary capillariosis (Sager et al., 2006, Sommerfelt et al., 2006, Claerebout et al., 2009, Lee et al., 2010, Traversa et al., 2010). Appropriate de-worming strategies based on the active monitoring of parasite distributions and the identification of specific risk factors, are considered fundamental to reduce the risk of infection in dogs and cats and to prevent human infections (Robben et al., 2004, Capelli et al., 2006, De Santis et al., 2006, Sager et al., 2006, Martìnez-Carrasco et al., 2007, Claerebout et al., 2009; http://www.esccap.org). However, despite the use of the recommended frequency of anthelmintic treatments, high yearly incidences of some intestinal nematode species (Toxocara canis, hookworms and Trichuris vulpis) were recently observed in dogs (Sager et al., 2006, Claerebout et al., 2009) and the incomplete effectiveness of the treatment was included among supposed causes of these findings (Sager et al., 2006). Furthermore, the anthelmintic resistance of some nematode species affecting dogs, including that of A. caninum against pyrantel, has been recently reported (Kopp et al., 2007, Kopp et al., 2008, Geary et al., 2011). Hence the importance to perform parasitological studies aimed to check the success of the treatment of infected dogs and cats, especially in the case of zoonotic species. According to the European Specialist Counsel Companion Animal Parasites (ESCCAP), the faecal egg count reduction test (FECRT) can be used in dogs and cats to assess the effectiveness of the treatment against nematode infections and a reduction in faecal egg count of 90% or more would be expected with most effective anthelmintics (http://www.esccap.org).

In Italy, few recent studies deal with distribution and risk factors of canine and feline intestinal and lung parasites in owned animals (Capelli et al., 2006, Traversa et al., 2010, Zanzani et al., 2010). Thus, the main aims of the present investigation were to obtain data on prevalence of intestinal and lung parasitic infections in owned dogs and cats in this part of the country and to identify potential risk factors.

Furthermore, the faecal egg count reduction test (FECRT) was also performed on some nematode infected animals in order to evaluate the absence/reduction of nematode eggs after the anthelmintic treatment.


Authors: Francesca Riggio, Riccardo Mannella, Gaetano Ariti, Stefania Perrucci

Source: https://www.sciencedirect.com/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Dr. Marjorie Bercier Publishes Study on Novel Diagnostic Approach for Prevalent Elephant Virus

Like0
Dislike0

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

Like0
Dislike0

Feline injection site sarcomas

Like0
Dislike0

C-reactive protein concentrations in canine acute pancreatitis

Like0
Dislike0

A retrospective clinical investigation of the safety and adverse effects of pantoprazole in hospitalized ruminants

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top